ProShare Advisors LLC Sells 10,955 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

ProShare Advisors LLC reduced its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 20.7% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 41,945 shares of the real estate investment trust’s stock after selling 10,955 shares during the period. ProShare Advisors LLC’s holdings in Sabra Health Care REIT were worth $646,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Natixis bought a new stake in Sabra Health Care REIT during the 1st quarter worth approximately $633,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of Sabra Health Care REIT by 63.6% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 318,808 shares of the real estate investment trust’s stock valued at $4,709,000 after acquiring an additional 123,966 shares in the last quarter. Cetera Advisors LLC grew its holdings in shares of Sabra Health Care REIT by 996.2% in the first quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust’s stock valued at $2,209,000 after acquiring an additional 135,929 shares in the last quarter. Cetera Investment Advisers grew its holdings in shares of Sabra Health Care REIT by 34.1% in the first quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust’s stock valued at $6,007,000 after acquiring an additional 103,413 shares in the last quarter. Finally, Renaissance Technologies LLC grew its holdings in shares of Sabra Health Care REIT by 77.0% in the second quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock valued at $19,824,000 after acquiring an additional 559,800 shares in the last quarter. 99.40% of the stock is owned by institutional investors.

Sabra Health Care REIT Trading Up 0.4 %

NASDAQ:SBRA opened at $18.44 on Monday. The company has a market cap of $4.32 billion, a P/E ratio of 92.20, a P/E/G ratio of 2.72 and a beta of 1.26. The stock’s fifty day moving average price is $17.14 and its two-hundred day moving average price is $15.46. Sabra Health Care REIT, Inc. has a 1 year low of $12.83 and a 1 year high of $19.32. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.27 and a quick ratio of 4.27.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, August 7th. The real estate investment trust reported $0.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.24). Sabra Health Care REIT had a return on equity of 1.87% and a net margin of 7.83%. The business had revenue of $176.14 million during the quarter, compared to analysts’ expectations of $166.54 million. During the same quarter last year, the business posted $0.34 EPS. The company’s quarterly revenue was up 9.3% on a year-over-year basis. As a group, analysts expect that Sabra Health Care REIT, Inc. will post 1.38 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 19th were given a $0.30 dividend. The ex-dividend date of this dividend was Monday, August 19th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.51%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.

Analyst Ratings Changes

SBRA has been the subject of several recent analyst reports. Truist Financial upped their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Citigroup raised Sabra Health Care REIT from a “neutral” rating to a “buy” rating and upped their target price for the company from $17.00 to $20.00 in a report on Friday, September 13th. Finally, Scotiabank upped their target price on Sabra Health Care REIT from $15.00 to $17.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Sabra Health Care REIT presently has an average rating of “Moderate Buy” and a consensus price target of $17.30.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.